The role of JNK proteins in metabolism

Science Translational Medicine

Volumn 2, Issue 60, 2010, Pages

  Vallerie, Sara N ^a,b   Hotamisligil, Gökhan S ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 70; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN;

APOPTOSIS; CARBOHYDRATE METABOLISM; CELL PROLIFERATION; DIMERIZATION; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; GLUCOSE METABOLISM; HETEROZYGOSITY; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; LIPOTOXICITY; LIVER CELL; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; UBIQUITINATION; ADIPOSE TISSUE; ANIMAL; BONE MARROW CELL; CENTRAL NERVOUS SYSTEM; ENERGY METABOLISM; LIVER; METABOLISM; PANCREAS ISLET BETA CELL; PHYSIOLOGICAL STRESS; PHYSIOLOGY; SKELETAL MUSCLE;

ADIPOSE TISSUE; ANIMALS; BONE MARROW CELLS; CENTRAL NERVOUS SYSTEM; ENERGY METABOLISM; HUMANS; INSULIN-SECRETING CELLS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIVER; METABOLIC DISEASES; MUSCLE, SKELETAL; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL;

EID: 78649878876     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3001007     Document Type: Review

References (53)

1. G. S. Hotamisligil, Inflammation and metabolic disorders. Nature 444, 860-867 (2006).
2. J. Hirosumi, G. Tuncman, L. Chang, C. Z. Görgün, K. T. Uysal, K. Maeda, M. Karin,G. S. Hotamisligil, A central role for JNK in obesity and insulin resistance. Nature 420, 333-336 (2002).
3. C. R.Weston, R. J. Davis, The JNK signal transduction pathway. Curr. Opin. Cell Biol. 19, 142-149 (2007).
4. G. Kroemer, G. Mariño, B. Levine, Autophagy and the integrated stress response. Mol. Cell 40, 280-293 (2010).
5. T. Nakamura, M. Furuhashi, P. Li, H. Cao, G. Tuncman, N. Sonenberg, C. Z. Gorgun, G. S. Hotamisligil, Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis. Cell 140, 338-348 (2010).
6. G. Tuncman, J. Hirosumi, G. Solinas, L. Chang, M. Karin, G. S. Hotamisligil, Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. Proc. Natl. Acad. Sci. U.S.A. 103, 10741-10746 (2006).
7. G. Boden, X. Duan, C. Homko, E. J. Molina, W. Song, O. Perez, P. Cheung, S. Merali, Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals. Diabetes 57, 2438-2444 (2008).
8. M. F. Gregor, L. Yang, E. Fabbrini, B. S. Mohammed, J. C. Eagon, G. S. Hotamisligil, S. Klein, Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss. Diabetes 58, 693-700 (2009).
9. 2-terminal kinase activity in subcutaneous adipose tissue but not nuclear factor-κB activity in peripheral blood mononuclear cells is an independent determinant of insulin resistance in healthy individuals. Diabetes 58, 1259-1265 (2009).
10. G.Waeber, J. Delplanque, C. Bonny, V. Mooser, M. Steinmann, C. Widmann, A. Maillard, J. Miklossy, C. Dina, E. H. Hani, N. Vionnet, P. Nicod, P. Boutin, P. Froguel, The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes. Nat. Genet. 24, 291-295 (2000).
11. Y. Nakatani, H. Kaneto, D. Kawamori, M. Hatazaki, T. Miyatsuka, T. A. Matsuoka, Y. Kajimoto, M. Matsuhisa, Y. Yamasaki, M. Hori, Modulation of the JNK pathway in liver affects insulin resistance status. J. Biol. Chem. 279, 45803-45809 (2004).
12. R. Singh, Y. Wang, Y. Xiang, K. E. Tanaka, W. A. Gaarde, M. J. Czaja, Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance. Hepatology 49, 87-96 (2009).
13. R. Yang, D. M. Wilcox, D. L. Haasch, P. M. Jung, P. T. Nguyen, M. J. Voorbach, S. Doktor, S. Brodjian, E. N. Bush, E. Lin, P. B. Jacobson, C. A. Collins, K. T. Landschulz, J. M. Trevillyan, C. M. Rondinone, T. K. Surowy, Liver-specific knockdown of JNK1 up-regulates proliferator-activated receptor γ coactivator 1β and increases plasma triglyceride despite reduced glucose and insulin levels in diet-induced obese mice. J. Biol. Chem. 282, 22765-22774 (2007).
14. M. Das, G. Sabio, F. Jiang, M. Rincón, R. A. Flavell, R. J. Davis, Induction of hepatitis by JNK-mediated expression of TNF-α. Cell 136, 249-260 (2009).
15. G. Sabio, J. Cavanagh-Kyros, H. J. Ko, D. Y. Jung, S. Gray, J. Y. Jun, T. Barrett, A. Mora, J. K. Kim, R. J. Davis, Prevention of steatosis by hepatic JNK1. Cell Metab. 10, 491-498 (2009).
16. L. J. Goodyear, P. Y. Chang, D. J. Sherwood, S. D. Dufresne, D. E. Moller, Effects of exercise and insulin on mitogen-activated protein kinase signaling pathways in rat skeletal muscle. Am. J. Physiol. 271, E403-E408 (1996).
17. Y. Leng, T. L. Steiler, J. R. Zierath, Effects of insulin, contraction, and phorbol esters on mitogen-activated protein kinase signaling in skeletal muscle from lean and ob/ob mice. Diabetes 53, 1436-1444 (2004).
18. 2- terminal kinase 1 in obesity-induced insulin resistance. Mol. Cell. Biol. 30, 106-115 (2010).
19. K. Morino, S. Neschen, S. Bilz, S. Sono, D. Tsirigotis, R. M. Reznick, I. Moore, Y. Nagai, V. Samuel, D. Sebastian, M. White, W. Philbrick, G. I. Shulman, Muscle-specific IRS-1 Ser→Ala transgenic mice are protected from fat-induced insulin resistance in skeletal muscle. Diabetes 57, 2644-2651 (2008).
20. J. Chung, A. K. Nguyen, D. C. Henstridge, A. G. Holmes, M. H. Chan, J. L. Mesa, G. I. Lancaster, R. J. Southgate, C. R. Bruce, S. J. Duffy, I. Horvath, R. Mestril, M. J. Watt, P. L. Hooper, B. A. Kingwell, L. Vigh, A. Hevener, M. A. Febbraio, HSP72 protects against obesity-induced insulin resistance. Proc. Natl. Acad. Sci. U.S.A. 105, 1739-1744 (2008).
21. A. V. Rozo, R. Vijayvargia, H. R. Weiss, H. Ruan, Silencing Jnk1 and Jnk2 accelerates basal lipolysis and promotes fatty acid re-esterification in mouse adipocytes. Diabetologia 51, 1493-1504 (2008).
22. G. Sabio, M. Das, A. Mora, Z. Zhang, J. Y. Jun, H. J. Ko, T. Barrett, J. K. Kim, R. J. Davis, A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 322, 1539-1543 (2008).
23. T. Kim, J. Wayne Leitner, R. Adochio, B. Draznin, Knockdown of JNK rescues 3T3-L1 adipocytes from insulin resistance induced by mitochondrial dysfunction. Biochem. Biophys. Res. Commun. 378, 772-776 (2009).
24. Y. H. Lee, J. Giraud, R. J. Davis, M. F. White, c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J. Biol. Chem. 278, 2896-2902 (2003).
25. B. K. Pedersen, M. A. Febbraio, Muscle as an endocrine organ: Focus on muscle-derived interleukin-6. Physiol. Rev. 88, 1379-1406 (2008).
26. S. P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, A. W. Ferrante Jr., Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796-1808 (2003).
27. H. Xu, G. T. Barnes, Q. Yang, G. Tan, D. Yang, C. J. Chou, J. Sole, A. Nichols, J. S. Ross, L. A. Tartaglia, H. Chen, Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112, 1821-1830 (2003).
28. M. T. Nguyen, H. Satoh, S. Favelyukis, J. L. Babendure, T. Imamura, J. I. Sbodio, J. Zalevsky, B. I. Dahiyat, N. W. Chi, J. M. Olefsky, JNK and tumor necrosis factor-α mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. J. Biol. Chem. 280, 35361-35371 (2005).
29. T. Suganami, J. Nishida, Y. Ogawa, A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: Role of free fatty acids and tumor necrosis factor α. Arterioscler. Thromb. Vasc. Biol. 25, 2062-2068 (2005).
30. Y. Kodama, T. Kisseleva, K. Iwaisako, K. Miura, K. Taura, S. De Minicis, C. H. Osterreicher, B. Schnabl, E. Seki, D. A. Brenner, c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice. Gastroenterology 137, 1467-1477.e5 (2009).
31. G. Solinas, C. Vilcu, J. G. Neels, G. K. Bandyopadhyay, J. L. Luo, W. Naugler, S. Grivennikov, A. Wynshaw-Boris, M. Scadeng, J. M. Olefsky, M. Karin, JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab. 6, 386-397 (2007).
32. S. N. Vallerie, M. Furuhashi, R. Fucho, G. S. Hotamisligil, A predominant role for parenchymal c-Jun amino terminal kinase (JNK) in the regulation of systemic insulin sensitivity. PLoS One 3, e3151 (2008).
33. R. Ricci, G. Sumara, I. Sumara, I. Rozenberg, M. Kurrer, A. Akhmedov, M. Hersberger, U. Eriksson, F. R. Eberli, B. Becher, J. Borén, M. Chen, M. I. Cybulsky, K. J. Moore, M. W. Freeman, E. F. Wagner, C. M. Matter, T. F. Lüscher, Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis. Science 306, 1558-1561 (2004).
34. J. C. Jonas, A. Sharma,W. Hasenkamp, H. Ilkova, G. Patanè, R. Laybutt, S. Bonner-Weir, G. C. Weir, Chronic hyperglycemia triggers loss of pancreatic b cell differentiation in an animal model of diabetes. J. Biol. Chem. 274, 14112-14121 (1999).
35. R. H. Unger, Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 44, 863-870 (1995).
36. A. Pick, J. Clark, C. Kubstrup, M. Levisetti, W. Pugh, S. Bonner-Weir, K. S. Polonsky, Role of apoptosis in failure of β-cell mass compensation for insulin resistance and β-cell defects in the male Zucker diabetic fatty rat. Diabetes 47, 358-364 (1998).
37. H. Kaneto, Y. Nakatani, T. Miyatsuka, D. Kawamori, T. A. Matsuoka, M. Matsuhisa, Y. Kajimoto, H. Ichijo, Y. Yamasaki, M. Hori, Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide. Nat. Med. 10, 1128-1132 (2004).
38. H. Kaneto, G. Xu, N. Fujii, S. Kim, S. Bonner-Weir, G. C. Weir, Involvement of c-Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression. J. Biol. Chem. 277, 30010-30018 (2002).
39. D. Kawamori, H. Kaneto, Y. Nakatani, T. A. Matsuoka, M. Matsuhisa, M. Hori, Y. Yamasaki, The forkhead transcription factor Foxo1 bridges the JNK pathway and the transcription factor PDX-1 through its intracellular translocation. J. Biol. Chem. 281, 1091-1098 (2006).
40. J. L. Varona-Santos, A. Pileggi, R. D. Molano, N. Y. Sanabria, A. Ijaz, M. Atsushi, H. Ichii, R. L. Pastori, L. Inverardi, C. Ricordi, A. Fornoni, c-Jun N-terminal kinase 1 is deleterious to the function and survival of murine pancreatic islets. Diabetologia 51, 2271-2280 (2008).
41. S. Abdelli, J. Puyal, C. Bielmann, V. Buchillier, A. Abderrahmani, P. G. Clarke, J. S. Beckmann, C. Bonny, JNK3 is abundant in insulin-secreting cells and protects against cytokine-induced apoptosis. Diabetologia 52, 1871-1880 (2009).
42. A. Jaeschke, M. Rincón, B. Doran, J. Reilly, D. Neuberg, D. L. Greiner, L. D. Shultz, A. A. Rossini, R. A. Flavell, R. J. Davis, Disruption of the Jnk2 (Mapk9) gene reduces destructive insulitis and diabetes in a mouse model of type I diabetes. Proc. Natl. Acad. Sci. U.S.A. 102, 6931-6935 (2005).
43. B. F. Belgardt, J. Mauer, F. T. Wunderlich, M. B. Ernst, M. Pal, G. Spohn, H. S. Brönneke, S. Brodesser, B. Hampel, A. C. Schauss, J. C. Brüning, Hypothalamic and pituitary c-Jun N-terminal kinase 1 signaling coordinately regulates glucose metabolism. Proc. Natl. Acad. Sci. U.S.A. 107, 6028-6033 (2010).
44. C. T. De Souza, E. P. Araujo, S. Bordin, R. Ashimine, R. L. Zollner, A. C. Boschero, M. J. Saad, L. A. Velloso, Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 146, 4192-4199 (2005).
45. E. K. Unger, M. L. Piper, L. E. Olofsson, A. W. Xu, Functional role of c-Jun-N-terminal kinase in feeding regulation. Endocrinology 151, 671-682 (2010).
46. G. Sabio, J. Cavanagh-Kyros, T. Barrett, D. Y. Jung, H. J. Ko, H. Ong, C. Morel, A. Mora, J. Reilly, J. K. Kim, R. J. Davis, Role of the hypothalamic-pituitary-thyroid axis in metabolic regulation by JNK1. Genes Dev. 24, 256-264 (2010).
47. N. Ouchi, A. Higuchi, K. Ohashi, Y. Oshima, N. Gokce, R. Shibata, Y. Akasaki, A. Shimono, K. Walsh, Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science 329, 454-457 (2010).
48. G. S. Hotamisligil, Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140, 900-917 (2010).
49. G. Liu, C. M. Rondinone, JNK: Bridging the insulin signaling and inflammatory pathway. Curr. Opin. Investig. Drugs 6, 979-987 (2005).
50. B. L. Bennett, Y. Satoh, A. J. Lewis, JNK: A new therapeutic target for diabetes. Curr. Opin. Pharmacol. 3, 420-425 (2003).
51. A. Ijaz, T. Tejada, P. Catanuto, X. Xia, S. J. Elliot, O. Lenz, A. Jauregui, M. O. Saenz, R. D. Molano, A. Pileggi, C. Ricordi, A. Fornoni, Inhibition of C-jun N-terminal kinase improves insulin sensitivity but worsens albuminuria in experimental diabetes. Kidney Int. 75, 381-388 (2009).
52. H. Cho, S. C. Black, D. Looper, M. Shi, D. Kelly-Sullivan, S. Timofeevski, K. Siegel, X. H. Yu, S. R. McDonnell, P. Chen, J. Yie, K. M. Ogilvie, J. Fraser, C. P. Briscoe, Pharmacological characterization of a small molecule inhibitor of c-Jun kinase. Am. J. Physiol. Endocrinol. Metab. 295, E1142-E1151 (2008).
53. J. L. Stebbins, S. K. De, T. Machleidt, B. Becattini, J. Vazquez, C. Kuntzen, L. H. Chen, J. F. Cellitti, M. Riel-Mehan, A. Emdadi, G. Solinas, M. Karin, M. Pellecchia, Identification of a new JNK inhibitor targeting the JNK-JIP interaction site. Proc. Natl. Acad. Sci. U.S.A. 105, 16809-16813 (2008).